HR1507-118

Introduced

To amend title 5, United States Code, to require disclosure of conflicts of interest with respect to rulemaking, and for other purposes.

118th Congress Introduced Mar 9, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill reforms federal rulemaking to reduce corporate influence and increase public participation. It requires disclosure of funding sources for studies submitted during rulemaking, creates penalties for companies that submit false information, establishes an Office of the Public Advocate, and codifies judicial deference to agency interpretations of ambiguous statutes.

Who Benefits and How

Consumer advocacy groups and the general public benefit from increased transparency requirements and a new Office of the Public Advocate to assist with rulemaking participation. Federal regulatory agencies gain stronger deference from courts for their regulatory interpretations. Small businesses and individuals benefit from reduced corporate dominance in the comment process.

Who Bears the Burden and How

Large corporations face new disclosure requirements for industry-funded studies and civil penalties up to $1 million for submitting false information. Industry trade associations must disclose funding conflicts when submitting research to agencies. OIRA faces stricter 60-day review deadlines for regulatory actions.

Key Provisions

  • Requires disclosure of funding sources and conflicts for all studies submitted during rulemaking
  • Imposes civil penalties of $250,000-$1,000,000 on public companies submitting false information to agencies
  • Creates Office of the Public Advocate to assist public participation and conduct social equity assessments
  • Codifies judicial deference to agency interpretations of ambiguous statutes
  • Limits OIRA review of significant regulatory actions to 60 days with one possible extension

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Reforms federal rulemaking processes to reduce corporate influence, increase transparency and public participation, and reinforce agency authority to issue regulations

Key Policy Areas

Administrative Law, Regulatory Policy, Government Transparency, Consumer Protection

Primary Purpose

Reforms federal rulemaking processes to reduce corporate influence, increase transparency and public participation, and reinforce agency authority to issue regulations

Policy Domains

Administrative Law Regulatory Policy Government Transparency Consumer Protection

Disclosure Requirements (Sections 4-7)

Identified Gains
Contextual inference, no direct clause citation
  • Public interest groups
  • Academic researchers
  • General public
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Corporations funding regulatory research
  • Industry trade associations
  • OIRA
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

OIRA Review Streamlining (Section 9)

Identified Gains
Contextual inference, no direct clause citation
  • Federal regulatory agencies
  • Public seeking faster regulation
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • OIRA
  • Industries benefiting from regulatory delay
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Findings and Sense of Congress (Sections 1-3)

Identified Gains
Contextual inference, no direct clause citation
  • Federal regulatory agencies
  • Consumer protection advocates
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Industry groups challenging regulations
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Judicial Review and Scope (Section 12)

Identified Gains
Contextual inference, no direct clause citation
  • Federal regulatory agencies
  • Public health and safety advocates
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Industries challenging agency regulations in court
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Penalties and Public Advocate (Sections 10-11)

Identified Gains
Contextual inference, no direct clause citation
  • Consumer advocates
  • Environmental groups
  • Underrepresented communities
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Public companies submitting rulemaking comments
  • Federal budget
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Public Participation (Sections 13-16)

Identified Gains
Contextual inference, no direct clause citation
  • General public
  • Advocacy organizations
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Federal agencies (compliance burden)
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Negotiated Rulemaking Reforms (Section 8)

Identified Gains
Contextual inference, no direct clause citation
  • Federal agencies
  • State/local/tribal governments
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Industry groups previously participating in negotiated rulemaking
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Cost-Benefit and Definitions (Sections 17-18)

Identified Gains
Contextual inference, no direct clause citation
  • Disadvantaged communities
  • Public health advocates
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Industries seeking to limit regulation through cost-benefit arguments
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Legislative Progress

Introduced
Introduced Committee Passed
Mar 9, 2023

Ms. Jayapal (for herself, Ms. Lee of California, Ms. Ocasio-Cortez, …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
12 mentions across 11 clauses
+4 positive -8 negative

Federal regulatory agencies, OIRA (Office of Information and Regulatory Affairs), Office of Management and Budget

Federal regulatory agencies faces effects in multiple directions

Advocacy Groups
7 mentions across 7 clauses
+7 positive

Community-based organizations, Consumer advocacy organizations, Consumer and environmental advocates

General Public
5 mentions across 4 clauses
+4 positive -1 negative

Federal budget/taxpayers, General public, General public seeking to participate in rulemaking

Positive-direction: General public, General public seeking to participate in rulemaking, Non-English speaking populations, Underrepresented communities and individuals

Negative-direction: Federal budget/taxpayers

Manufacturing
3 mentions across 3 clauses
-3 negative

Corporations funding regulatory research, Industries benefiting from withdrawn regulations, Industries seeking to limit regulation through cost-benefit arguments

Professional Services
2 mentions across 2 clauses
+1 positive -1 negative

Corporate legal and compliance departments, Industries challenging agency regulations in court

Positive-direction: Corporate legal and compliance departments

Negative-direction: Industries challenging agency regulations in court

Business Associations
2 mentions across 2 clauses
-2 negative

Industry trade associations, Industry trade associations previously participating in negotiated rulemaking

Research & Science
2 mentions across 2 clauses
-2 negative

Contract research organizations, Industry-funded researchers

Small Business
1 mention across 1 clause
+1 positive

Small businesses affected by regulations

14/19
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Administrative Law
Domains
Government Transparency Regulatory Policy
Actor Mappings
"the_agency"
→ Any federal agency conducting rulemaking
"the_office"
→ Office of Information and Regulatory Affairs (OIRA)
Domains
Administrative Law
Domains
Regulatory Policy
Actor Mappings
"the_office"
→ Office of Information and Regulatory Affairs (OIRA)
Domains
Consumer Protection Government Transparency
Actor Mappings
"the_national_public_advocate"
→ National Public Advocate (new position in OMB)
Domains
Administrative Law
Domains
Government Transparency
Domains
Regulatory Policy

Key Definitions

Terms defined in this bill

7 terms
"agency" §18_agency

Has the meaning given in section 551 of title 5, United States Code

"Office" §18_office

The Office of Information and Regulatory Affairs of the Office of Management and Budget

"interested person" §18_interested_person

Includes individuals, partnerships, corporations, associations, or public or private organizations of any character other than an agency

"regulatory action" §18_regulatory_action

Any substantive action by an agency that promulgates or is expected to lead to the promulgation of a final rule or regulation

"social equity impact" §18_social_equity_impact

Any impact of a proposed rule that might disproportionately affect a population that is part of a protected class

"social equity assessment" §18_social_equity_assessment

A written report considering social equity impacts on populations within protected classes

"significant regulatory action" §18_significant_regulatory_action

Any regulatory action likely to result in a rule with $100M+ annual economic effect, cross-agency conflicts, budgetary impacts, or novel legal issues

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology